Explore how batch variability impacts bioequivalence standards. Learn why the 80-125% rule may be flawed and how new Between-Batch methods improve generic drug safety.
May, 7 2026
Oct, 21 2025
Jan, 3 2026
Sep, 23 2025
Dec, 22 2025